Litcius/Paper detail

The next frontier of healthcare-associated infection (HAI) surveillance metrics: Beyond device-associated infections

Sonali D. Advani, Kelly Cawcutt, Michael Klompas, Jonas Marschall, Jennifer Meddings, Payal Patel

2024Infection Control and Hospital Epidemiology11 citationsDOI

Abstract

Abstract In recent years, it has become increasingly evident that surveillance metrics for invasive device-associated infections (ie, central-line–associated bloodstream infections, ventilator-associated pneumonias, and catheter-associated urinary tract infections) do not capture all harms; they capture only a subset of healthcare-associated infections (HAIs). Although prevention of device-associated infections remains critical, we need to address the full spectrum of potential harms from device use and non–device-associated infections. These include complications associated with additional devices, such as peripheral venous and arterial catheters, non–device-associated infections such as nonventilator hospital-acquired pneumonia, and noninfectious device complications such as trauma, thrombosis, and acute lung injury. As authors of the device-associated infection sections in the SHEA/IDSA/APIC Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals , we highlight catheter-associated urinary tract infection as an example of the strengths and limitations of the current emphasis on device-associated infection surveillance, suggest performance metrics that present a more comprehensive picture of patient harm, and provide a high-level overview of similar issues with other infection surveillance measures.

Topics & Concepts

MedicineIntensive care medicineInfection controlPneumoniaHealth careBacteremiaDeep veinUrinary systemThrombosisInternal medicineAntibioticsBiologyEconomic growthEconomicsMicrobiologyUrinary Tract Infections ManagementCentral Venous Catheters and HemodialysisPatient Satisfaction in Healthcare
The next frontier of healthcare-associated infection (HAI) surveillance metrics: Beyond device-associated infections | Litcius